STAT Podcast: Merck-Moderna mRNA Cancer Vaccine Data — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- The Readout LOUD brought in STAT colleague Andrew Joseph to work through the latest cancer data presented at the annual meeting of the European Society for Medical Oncology.
- Merck and Moderna's mRNA cancer vaccine was the lead item, with the hosts detailing how doctors reacted to the fuller data set.
- Adam Feuerstein joined the conversation to discuss what he is doing in Spain and the next big advances in oncology.
- Amgen's lung cancer data and Roche's results were linked as further readouts from the ESMO meeting covered by STAT.
- Apple Podcasts and Spotify carry the new episode, and the team also folded in an announcement about the podcast itself.
Why it matters: For Merck and Moderna, the episode's focus on detailed data and doctors' reactions puts the mRNA cancer vaccine ahead of Amgen's lung cancer and Roche's results in the coverage agenda, while one listen also delivers Adam Feuerstein's Spain update and a read on oncology's next advances.
Ask SkimNews
